These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 36183925)
1. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA. Zhang B; He Y; Ma G; Zhang L; Qi P; Han D; Yue Z; Shang P Mol Cell Probes; 2022 Dec; 66():101867. PubMed ID: 36183925 [TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis. Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D Front Oncol; 2021; 11():641184. PubMed ID: 33816287 [TBL] [Abstract][Full Text] [Related]
3. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices. Pan S; Zhan Y; Chen X; Wu B; Liu B Front Oncol; 2019; 9():613. PubMed ID: 31334127 [No Abstract] [Full Text] [Related]
4. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
5. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
6. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers. Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis. Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209 [TBL] [Abstract][Full Text] [Related]
8. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices. Xia P; Li Q; Wu G; Huang Y J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841 [TBL] [Abstract][Full Text] [Related]
9. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer. Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer. Lin YZ; Wu YP; Ke ZB; Cai H; Chen DN; Chen SH; Li XD; Lin TT; Huang JB; Zheng QS; Xue XY; Xu N; Wei Y Med Sci Monit; 2020 Apr; 26():e920504. PubMed ID: 32277695 [TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. Zhang H; Cao C; Xiong H Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509 [TBL] [Abstract][Full Text] [Related]
12. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma. Tang R; Liu X; Wang W; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S Front Oncol; 2021; 11():643465. PubMed ID: 33912458 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model. Li C; Yao W; Zhao C; Yang G; Wei J; Qi Y; Huang R; Zhao Q; Hao C Biomed Res Int; 2020; 2020():3075729. PubMed ID: 33381546 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related]
15. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer. Li M; Liu Y; Zhang X; Liu J; Wang P Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927 [TBL] [Abstract][Full Text] [Related]
17. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
18. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis. Pei J; Wang Y; Li Y J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983 [TBL] [Abstract][Full Text] [Related]
19. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma. Chen M; Wang X; Wang W; Gui X; Li Z Front Immunol; 2022; 13():829057. PubMed ID: 35833114 [TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]